Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Bladder Cancer

  Free Subscription


Articles published in Urol Int

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    May 2025
  1. LU Y, Wu H, Jiang J, Bao S, et al
    The value of circulating tumor DNA in the prognostic diagnosis of bladder cancer: a systematic review and meta-analysis.
    Urol Int. 2025 May 2:1-17. doi: 10.1159/000546014.
    PubMed     Abstract available


    April 2025
  2. MUNKER KA, Reineke D, Schneidewind L, Mussgens C, et al
    A rare case of a plasmacytoid and sarcomatoid differentiated urothelial bladder carcinoma with a single metastasis to the right ventricle of the heart and rapid review of single heart metastasis in bladder cancer.
    Urol Int. 2025 Apr 26:1-15. doi: 10.1159/000546149.
    PubMed     Abstract available


    March 2025
  3. PYRGIDIS N, Volz Y, Takayama Fouladgar S, Ebner B, et al
    The role of radical cystectomy with orthotopic neobladder reconstruction in patients developing bladder cancer after prior radical prostatectomy, radiation therapy or BPH surgery.
    Urol Int. 2025 Mar 6:1-17. doi: 10.1159/000545103.
    PubMed     Abstract available


    February 2025
  4. LIU R, Zhang Y, Zhou Z
    Patient-Derived Bladder Cancer Organoids: Model Construction and Drug Sensitivity Testing.
    Urol Int. 2025 Feb 10:1-16. doi: 10.1159/000543983.
    PubMed     Abstract available


    January 2025
  5. CHEN H, Wu M, Chen M
    Prognostic Significance of Albumin-Globulin Ratio in Urachal Carcinoma.
    Urol Int. 2025;109:8-17.
    PubMed     Abstract available


  6. ELSAEED K, Moustafa H, Abdelghani S, ElAwady H, et al
    Anti-Reflux Ureteroileal Anastomosis for Orthotopic Ileal Neobladder Using Wallace Technique in a Single Trough.
    Urol Int. 2025;109:182-188.
    PubMed     Abstract available


  7. ELLEISY M, Zettl H, Drager DL, Hakenberg OW, et al
    The Impact of Diabetes and Antidiabetics on Uro-Oncological Disease Outcomes: A Single-Center Experience.
    Urol Int. 2025;109:361-371.
    PubMed     Abstract available


  8. YANG Y, Holbach S, Haas M, Engelmann SU, et al
    Does Time Matter in Early Radical Cystectomy? Comparing Outcome, Clinical, and Pathological Characteristics of Immediate versus Deferred Radical Cystectomy.
    Urol Int. 2025;109:315-322.
    PubMed     Abstract available


  9. AL-NADER M, Krafft U, Darr C, Hess J, et al
    Outcomes of Surgical Therapy for Local Recurrence and Oligometastatic Urothelial Carcinoma of the Bladder: 20 Years of Experience in a Tertiary Center.
    Urol Int. 2025;109:337-345.
    PubMed     Abstract available


  10. SCHNEIDEWIND L, Kiss B, Kranz J, Zengerling F, et al
    Gender-Specific Differences in Recurrence and Progression following Bacillus Calmette-Guerin Instillation for Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2025;109:412-424.
    PubMed     Abstract available


    December 2024
  11. TULLY K, Bahlburg H, Reike MJ, Brehmer M, et al
    Discrimination of T-stage using tumor weight and size - a potential approach to guide perioperative decision making in patients with bladder cancer.
    Urol Int. 2024 Dec 16:1-15. doi: 10.1159/000543112.
    PubMed     Abstract available


    September 2024
  12. OZER MS, Incir C, Yildiz HA, Deger MD, et al
    Comparison of tissue and urine microbiota in male, intervention naive patients with and without non-invasive bladder cancer.
    Urol Int. 2024 Sep 21:1-13. doi: 10.1159/000541296.
    PubMed     Abstract available


    August 2024
  13. CARL N, Schmidt L, Buedenbender B, Blum AK, et al
    Body image perception and social support are important predictors of quality of life in bladder cancer patients after cystectomy with urinary diversion.
    Urol Int. 2024 Aug 30. doi: 10.1159/000541223.
    PubMed     Abstract available


  14. SCHEPER V, Seitz AK, Kubler H, Kocot A, et al
    A propensity-score based comparison regarding renal, functional and surgical outcome of continent cutaneous urinary diversions in patients with benign chronic bladder diseases and patients with bladder cancer.
    Urol Int. 2024 Aug 16. doi: 10.1159/000540950.
    PubMed     Abstract available


    May 2024
  15. CHO HJ, Chung HS, Hwang EC, Jung SI, et al
    Music from noise-canceling headphones is beneficial against anxiety in male bladder cancer patients undergoing follow-up cystoscopy: A prospective randomized trial.
    Urol Int. 2024 May 10. doi: 10.1159/000539312.
    PubMed     Abstract available


    March 2024
  16. DUAN H, Deng Z, Zou J, Zhang G, et al
    The efficacy and safety of Hyperthermia intravesical chemotherapy in the treatment non-muscle invasive bladder cancer:A meta analysis.
    Urol Int. 2024 Mar 20. doi: 10.1159/000538373.
    PubMed     Abstract available


    January 2024
  17. REIKE MJ, Reicherz A, Tully KH, Bahlburg H, et al
    An empirical survey on the adaption of neoadjuvant chemotherapy in bladder cancer.
    Urol Int. 2024 Jan 19. doi: 10.1159/000536321.
    PubMed     Abstract available


  18. BANEK S, Hoeh B, Cano Garcia C, Koll F, et al
    Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies.
    Urol Int. 2024;108:1-8.
    PubMed     Abstract available


  19. VOLZ Y, Trappmann R, Ebner B, Eismann L, et al
    Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive Cancer of the Bladder: Who Is at Highest Risk?
    Urol Int. 2024;108:42-48.
    PubMed     Abstract available


  20. GARAZ R, Stuhler V, Stenzl A, Rottscholl R, et al
    Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis, Histology, and Treatment Options.
    Urol Int. 2024;108:83-88.
    PubMed     Abstract available


  21. WALACH MT, Nitschke K, Gross-Weege M, Grosshans J, et al
    Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract Urothelial Carcinoma.
    Urol Int. 2024;108:128-136.
    PubMed     Abstract available


  22. OZCAN L, Polat EC, Baran C, Boylu A, et al
    Systemic Inflammatory Index: A Promising Non-Invasive Marker for the Prediction of Response to Neoadjuvant Chemotherapy prior to Cystectomy.
    Urol Int. 2024;108:226-233.
    PubMed     Abstract available


  23. BANEK S, Wenzel M, Lauer B, Le QC, et al
    Real-World Evidence of Tumor and Patient Characteristics and Survival with Avelumab Maintenance after Chemotherapy for Advanced and Metastatic Urothelial Carcinoma.
    Urol Int. 2024;108:285-291.
    PubMed     Abstract available


  24. PYRGIDIS N, Schulz GB, Volz Y, Ebner B, et al
    The Prognostic Value of Perioperative Platelet and Leukocyte Values in Patients Undergoing Radical Cystectomy: A Prospective Long-Term Cohort Study.
    Urol Int. 2024;108:421-428.
    PubMed     Abstract available


  25. CHEN H, Wu M, Chen M
    Evaluation of the Management of Urachal Carcinoma: A Single-Center Experience over 13 Years.
    Urol Int. 2024;108:508-516.
    PubMed     Abstract available


    December 2023
  26. GUO Y, Li C, Zhang S, Zhu G, et al
    U-Net-Based Assistive Identification of Bladder Cancer: A Promising Approach for Improved Diagnosisc.
    Urol Int. 2023 Dec 11. doi: 10.1159/000535652.
    PubMed     Abstract available


    November 2023
  27. GUO L, Zhang T, Taisheng L, Chen J, et al
    Laparoscopic Radical Cystectomy With Ileal Orthotopic Neobladder for Bladder Cancer: Current Indications and Outcomes.
    Urol Int. 2023 Nov 23. doi: 10.1159/000535032.
    PubMed     Abstract available


    September 2023
  28. CHEN Z
    The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway.
    Urol Int. 2023 Sep 4:1-9. doi: 10.1159/000532128.
    PubMed     Abstract available


    August 2023
  29. JIAO H, Wang L, Zhou X, Wu J, et al
    Prognostic Ability of Nutritional Indices for Outcomes of Bladder Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2023 Aug 29:1-9. doi: 10.1159/000531884.
    PubMed     Abstract available


    June 2023
  30. DU J, Zhan H, Chen J, Wang J, et al
    The Influence of Preoperative Hydronephrosis on the Prognosis after Radical Cystectomy among Patients with Different Pathological Stages of Bladder Cancer.
    Urol Int. 2023 Jun 2:1-8. doi: 10.1159/000531080.
    PubMed     Abstract available


    March 2023
  31. FU Y, Liu K, Jiang X, Zhao L, et al
    Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis.
    Urol Int. 2023 Mar 23:1-14. doi: 10.1159/000527873.
    PubMed     Abstract available


    January 2023
  32. HAAS M, Knobloch C, Mayr R, Gierth M, et al
    Short-Term and Long-Term Morbidity after Radical Cystectomy in Patients with NMIBC and Comparison with MIBC: Identifying Risk Factors for Severe Short-Term Complications.
    Urol Int. 2023;107:246-256.
    PubMed     Abstract available


  33. MEYER HJ, Wienke A, Zamsheva M, Surov A, et al
    Low Skeletal Muscle Mass Predicts Relevant Outcomes in Palliative Urological Oncology: A Systematic Review and Meta-Analysis.
    Urol Int. 2023;107:219-229.
    PubMed     Abstract available


  34. CHEN S, Gao Y, Chen F, Wang TB, et al
    ANLN Serves as an Oncogene in Bladder Urothelial Carcinoma via Activating JNK Signaling Pathway.
    Urol Int. 2023;107:310-320.
    PubMed     Abstract available


  35. HAEUSER L, Marchese M, Noldus J, Kibel AS, et al
    Association between Operative Time and Short-Term Radical Cystectomy Complications.
    Urol Int. 2023;107:273-279.
    PubMed     Abstract available


  36. GRUNE B, Menold H, Lenhart M, Muhlbauer J, et al
    Patient Compliance in Assessing Electronic Patient-Reported Outcome Measures after Urologic Surgery.
    Urol Int. 2023;107:280-287.
    PubMed     Abstract available


  37. BOLENZ C, Kunath F, Zengerling F, Wezel F, et al
    Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical Trials.
    Urol Int. 2023;107:480-488.
    PubMed     Abstract available


  38. GRUNE B, Kowalewski KF, Weiss C, Neuberger M, et al
    Predicting Complexity in Transurethral Resection of Bladder Tumours: External Validation and Modification of the Bladder Complexity Score.
    Urol Int. 2023;107:583-590.
    PubMed     Abstract available


  39. WU YL, Li ZQ, Wu AM
    The Misdiagnosis of Intravesical Ectopic Prostatic Tissue as a Tumor.
    Urol Int. 2023;107:738-741.
    PubMed     Abstract available


  40. STRUCK JP, Ozimek T, Schnoor M, Offermann A, et al
    The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours.
    Urol Int. 2023;107:792-800.
    PubMed     Abstract available


  41. BOKARICA P, Alfirevic M, Hrkac A, Glas AM, et al
    Letter to the Editor regarding the Article "Postoperative Mortality Rate after Radical Cystectomy: A Systematic Review of Epidemiologic Series".
    Urol Int. 2023;107:839-840.
    PubMed    


  42. SHEN C, Zhang DL, Cheng XL, Zhang WC, et al
    Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Urol Int. 2023;107:841-847.
    PubMed     Abstract available


  43. YUAN P, Li X, Yuan Y, Xu P, et al
    Successful Kidney-Sparing Systemic Therapy for a High-Risk Ureteral Carcinoma Case.
    Urol Int. 2023;107:895-898.
    PubMed     Abstract available


  44. WANG C, Yu H, Fu W, Chen G, et al
    Transurethral Hem-o-lok Clip Ligation of the Distal Ureter in Retroperitoneal Laparoscopic Radical Nephroureterectomy.
    Urol Int. 2023;107.
    PubMed     Abstract available


  45. TULONE G, Pavan N, Giannone S, Abrate A, et al
    Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study.
    Urol Int. 2023;107.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.